Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...
Argentina's gene-edited horses
Scientists in the polo-obsessed nation have produced world's first genetically edited horses, designed to outrun champion ...